Cliff Asness's OLMA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 81,167 shares of Olema Pharmaceuticals, Inc. (OLMA) worth $2.03 M, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in OLMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 45,661 shares. Largest reduction occurred in Q3 2022, reducing 70,973 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Olema Pharmaceuticals (OLMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Olema Pharmaceuticals (OLMA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -14 | Reduce 0.02% | 81,167 | $25.00 |
| Q3 2025 | -1,694 | Reduce 2.04% | 81,181 | $9.79 |
| Q2 2025 | +37,214 | Add 81.50% | 82,875 | $4.26 |
| Q1 2025 | +45,661 | New Buy | 45,661 | $3.76 |
| Q3 2024 | -12,125 | Sold Out | 0 | $0.00 |
| Q2 2024 | +704 | Add 6.16% | 12,125 | $10.82 |
| Q1 2024 | +640 | Add 5.94% | 11,421 | $11.32 |
| Q4 2023 | +728 | Add 7.24% | 10,781 | $14.03 |
| Q3 2023 | +10,053 | New Buy | 10,053 | $12.35 |
| Q3 2022 | -70,973 | Sold Out | 0 | $0.00 |
| Q2 2022 | +29,457 | Add 70.95% | 70,973 | $4.07 |
| Q1 2022 | +41,516 | New Buy | 41,516 | $4.26 |
Cliff Asness's Olema Pharmaceuticals Investment FAQs
Cliff Asness first purchased Olema Pharmaceuticals, Inc. (OLMA) in Q1 2022, acquiring 41,516 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Olema Pharmaceuticals, Inc. (OLMA) for 12 quarters since Q1 2022.
Cliff Asness's largest addition to Olema Pharmaceuticals, Inc. (OLMA) was in Q1 2025, adding 45,661 shares worth $171,686.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 81,167 shares of Olema Pharmaceuticals, Inc. (OLMA), valued at approximately $2.03 M.
As of the Q4 2025 filing, Olema Pharmaceuticals, Inc. (OLMA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Olema Pharmaceuticals, Inc. (OLMA) was 82,875 shares, as reported at the end of Q2 2025.